United Says CEO is ‘Recovering Well’ from Heart Transplant
The transplant offered a “preferable” outcome versus an implanted medical device that Munoz been progressing well with, and was not a “setback in his recovery,” the airline said.
The former railroad CEO, who took up his duties at United in September, suffered a heart attack in mid October but had been gradually resuming company-related meetings and activities since early December.
The statement issued on Thursday quoted Dr. Patrick McCarthy, chief of cardiac surgery at Chicago’s Northwestern Memorial Hospital, where the surgery took place. “Given Mr. Munoz’s excellent physical condition and the rapid pace of his recovery prior to the transplant, we expect a quick recovery and a return to his duties as CEO,” he said.
The outlook for heart transplant patients varies greatly. Each patient reacts differently to the cyclosporine-based immunosuppression drug regimen that is required to ward of rejection of the organ, and the survival rate after one year for such patients is approximately 85% to 90%. The three-year survival rate approaches 75%, while the five- and ten-year rate is approximately 68% and 46% respectively.
(Photo: Accura Media Group)